Astrazeneca AZN
NYSE AZN
$164.56 -0.37 (-0.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Astrazeneca (AZN) EBT Margin (2009 - 2026)

Astrazeneca (AZN) posted quarterly EBT Margin of 18.81% for Q2 2026, down 579.0% year-over-year from 3.93% in Q2 2025, and down 99.63% quarter-over-quarter from 5083.12% in Q1 2026.

Astrazeneca (AZN) EBT Margin (2009 - 2026) Analysis & Trends

Astrazeneca's EBT Margin history runs 18 years deep, the most recent figure standing at 18.81% for Q2 2026.

  • In Q2 2026, EBT Margin fell 579.0% year-over-year to 18.81%; the TTM figure through Jun 2026 stood at 81.93% (up 1407.0% YoY), while the FY2025 annual figure was 22.02%, up 595.0% from the prior year.
  • EBT Margin for Q2 2026 stood at 18.81%, down from 5083.12% in the prior quarter.
  • The five-year high for EBT Margin was 59925.0% in Q2 2024, with the low at 18.81% in Q2 2026.
  • The 5-year median for EBT Margin is 2495.84% (2023), against an average of 9721.97%.
  • The sharpest annual moves came in 2024 and 2025: EBT Margin soared 5884313 bps in 2024, then slumped 5990040 bps in 2025.
  • Astrazeneca's EBT Margin stood at 492.41% in 2022, then soared by 285 bps to 1893.38% in 2023, then tumbled by 89 bps to 204.42% in 2024, then soared by 21335 bps to 43816.67% in 2025, then plunged by 100 bps to 18.81% in 2026.
  • Business Quant data shows AZN's EBT Margin at 18.81% in Q2 2026, 5083.12% in Q1 2026, and 43816.67% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 26.66%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 25.18%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -4.11%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 29.63%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 18.19%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 27.53%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -131.41%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -4.34%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 4.21%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 127.52%

Historic Data

Download Data
DateValue
Jun 30, 2026 18.81%
Mar 31, 2026 5,083.12%
Dec 31, 2025 43,816.67%
Sep 30, 2025 29,490.91%
Jun 30, 2025 24.60%
Mar 31, 2025 4,597.30%
Dec 31, 2024 204.42%
Sep 30, 2024 3,098.31%
Jun 30, 2024 59,925.00%
Mar 31, 2024 6,222.22%
Dec 31, 2023 1,893.38%
Sep 30, 2023 1,703.09%
Jun 30, 2023 1,081.87%
Mar 31, 2023 8,377.78%
Dec 31, 2022 492.41%
Sep 30, 2022 517.98%
Jun 30, 2022 8,233.33%
Mar 31, 2022 214.34%
Dec 31, 2021 -123.98%
Sep 30, 2021 -1,600.80%